| Prostate cancer in primary care SWD Merriel, G Funston, W Hamilton Advances in therapy 35 (9), 1285-1294, 2018 | 260 | 2018 |
| The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study G Funston, W Hamilton, G Abel, EJ Crosbie, B Rous, FM Walter PLoS medicine 17 (10), e1003295, 2020 | 130 | 2020 |
| Recognising skin cancer in primary care OT Jones, CKI Ranmuthu, PN Hall, G Funston, FM Walter Advances in therapy 37 (1), 603-616, 2020 | 127 | 2020 |
| Medical student perceptions of research and research-orientated careers: an international questionnaire study G Funston, RJ Piper, C Connell, P Foden, AMH Young, P O’Neill Medical teacher 38 (10), 1041-1048, 2016 | 98 | 2016 |
| Recognizing gynecological cancer in primary care: risk factors, red flags, and referrals G Funston, H O’Flynn, NAJ Ryan, W Hamilton, EJ Crosbie Advances in therapy 35, 577-589, 2018 | 97 | 2018 |
| Expression of heterologous genes in oncolytic adenoviruses using picornaviral 2A sequences that trigger ribosome skipping GM Funston, SE Kallioinen, P de Felipe, MD Ryan, RD Iggo Journal of General virology 89 (2), 389-396, 2008 | 80 | 2008 |
| Associations between breast cancer survivorship and adverse mental health outcomes: A matched population-based cohort study in the United Kingdom H Carreira, R Williams, G Funston, S Stanway, K Bhaskaran PLoS medicine 18 (1), e1003504, 2021 | 63 | 2021 |
| Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines G Funston, M Van Melle, MLL Baun, H Jensen, C Helsper, J Emery, ... BMC cancer 19, 1-13, 2019 | 38 | 2019 |
| Identifying ovarian cancer in symptomatic women: a systematic review of clinical tools G Funston, V Hardy, G Abel, EJ Crosbie, J Emery, W Hamilton, FM Walter Cancers 12 (12), 3686, 2020 | 28 | 2020 |
| The performance of HE4 alone and in combination with CA125 for the detection of ovarian cancer in an enriched primary care population CE Barr, G Funston, D Jeevan, S Sundar, LTA Mounce, EJ Crosbie Cancers 14 (9), 2124, 2022 | 27 | 2022 |
| CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: A retrospective cohort study using electronic health records G Funston, LTA Mounce, S Price, B Rous, EJ Crosbie, W Hamilton, ... British Journal of General Practice 71 (707), e465-e472, 2021 | 25 | 2021 |
| The promotion of academic medicine through student-led initiatives G Funston International journal of medical education 6, 155, 2015 | 25 | 2015 |
| Improving the timely detection of bladder and kidney cancer in primary care Y Zhou, G Funston, G Lyratzopoulos, FM Walter Advances in therapy 36, 1778-1785, 2019 | 20 | 2019 |
| Perceived barriers to research in undergraduate medicine CD Russell, AL McLean, KE MacGregor, FR Millar, AMH Young, ... Medical Teacher 34 (9), 777-778, 2012 | 19 | 2012 |
| Binding of translationally controlled tumour protein to the N-terminal domain of HDM2 is inhibited by nutlin-3 G Funston, W Goh, SJ Wei, QS Tng, C Brown, L Jiah Tong, C Verma, ... Public Library of Science 7 (8), e42642, 2012 | 19 | 2012 |
| Pre-diagnostic clinical features and blood tests in patients with colorectal cancer: a retrospective linked-data study M Moullet, G Funston, LTA Mounce, GA Abel, N de Wit, FM Walter, Y Zhou British Journal of General Practice 72 (721), e556-e563, 2022 | 18 | 2022 |
| The road to a clinical academic career G Funston, C Cerra, D Kirkham, G Doherty, P O’Neill BMJ 350, 2015 | 18 | 2015 |
| Recognising colorectal cancer in primary care N Calanzani, A Chang, M Van Melle, MM Pannebakker, G Funston, ... Advances in Therapy 38 (5), 2732-2746, 2021 | 17 | 2021 |
| Identifying novel biomarkers ready for evaluation in low-prevalence populations for the early detection of upper gastrointestinal cancers: a systematic review N Calanzani, PE Druce, C Snudden, KM Milley, R Boscott, D Behiyat, ... Advances in therapy 38, 793-834, 2021 | 15 | 2021 |
| Comparison of two immunoassays for the measurement of serum HE4 for ovarian cancer CE Barr, G Funston, LTA Mounce, PW Pemberton, JD Howe, EJ Crosbie Practical Laboratory Medicine 26, e00235, 2021 | 14 | 2021 |
